In this study, using RNA-seq data from the TCGA database and in-house immunohistochemical staining of tumor resections, we identified CD70-expressing tumor cells and CAFs as a promising therapeutic target in PDAC and CRC patients. This evidence concerns the gene CD70 and colorectal carcinoma.